352 related articles for article (PubMed ID: 22268731)
1. Hyper-IgE syndrome update.
Sowerwine KJ; Holland SM; Freeman AF
Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
4. An update on the hyper-IgE syndromes.
Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
[TBL] [Abstract][Full Text] [Related]
5. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of hyper IgE syndrome.
Heimall J; Freeman A; Holland SM
Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
[TBL] [Abstract][Full Text] [Related]
7. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
Tsilifis C; Freeman AF; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
Oikonomopoulou C; Goussetis E
Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
[TBL] [Abstract][Full Text] [Related]
9. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation.
Jin H; Yu Z; Navarengom K; Liu Y; Dmitrieva N; Hsu AP; Schwartzbeck R; Cudrici C; Ferrante EA; Yang D; Holland SM; Freeman AF; Boehm M; Chen G
Stem Cell Res; 2019 Dec; 41():101586. PubMed ID: 31707214
[TBL] [Abstract][Full Text] [Related]
10. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
11. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
13. B-cell-specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome.
Kane A; Lau A; Brink R; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2016 Nov; 138(5):1455-1458.e3. PubMed ID: 27423495
[No Abstract] [Full Text] [Related]
14. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
15. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
16. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).
Heimall J; Davis J; Shaw PA; Hsu AP; Gu W; Welch P; Holland SM; Freeman AF
Clin Immunol; 2011 Apr; 139(1):75-84. PubMed ID: 21288777
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
18. Reduced bone density in patients with autosomal dominant hyper-IgE syndrome.
Scheuerman O; Hoffer V; Cohen AH; Woellner C; Grimbacher B; Garty BZ
J Clin Immunol; 2013 Jul; 33(5):903-8. PubMed ID: 23606327
[TBL] [Abstract][Full Text] [Related]
19. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
20. A deep intronic splice mutation of
Khourieh J; Rao G; Habib T; Avery DT; Lefèvre-Utile A; Chandesris MO; Belkadi A; Chrabieh M; Alwaseem H; Grandin V; Sarrot-Reynauld F; Sénéchal A; Lortholary O; Kong XF; Boisson-Dupuis S; Picard C; Puel A; Béziat V; Zhang Q; Abel L; Molina H; Marr N; Tangye SG; Casanova JL; Boisson B
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16463-16472. PubMed ID: 31346092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
